NFKB1 and thyroid gland carcinoma: These studies have shed more light on the main oncogenic upstream pathways able to drive NF-κB activation in thyroid cancer, especially in the highly malignant progression of thyroid neoplastic cells, and overall have clearly established that both NF-κB canonical and non-canonical signaling are involved in thyroid carcinomas.